Table 4.
Sarcopenia criteria and muscle function status of COPD cases and controls
| Variables | COPD (n = 111) | Control (n = 111) | P-value* |
|---|---|---|---|
| 6MWT (m) | 429.95 ± 76.59 | 565.97 ± 384.85 | < 0.001 |
| pre.O2 (%) | 92.66 ± 3.92 | 96.29 ± 1.17 | < 0.001 |
| post.O2 (%) | 89.95 ± 5.83 | 95.50 ± 1.39 | < 0.001 |
| 5STS (s) | 12.85 ± 4.13 | 8.62 ± 2.13 | < 0.001 |
| Right hand.grip (kg) | 29.67 ± 7.95 | 37.81 ± 8.19 | < 0.001 |
| Left hand.grip (kg) | 28.30 ± 7.86 | 36.85 ± 8.33 | < 0.001 |
| SMI (kg/m2) | 9.89 ± 1.28 | 10.97 ± 1.21 | < 0.001 |
Values are indicated as mean ± standard deviation
Independent sample T-test was applied for groups comparison
6MWT 6 min walking test, 5STS 5 sit to stand, SMI skeletal muscle index
*The p < 0.05 was considered as significant